Health Care·Health Care Equipment·$92.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.35 | N/A | -5.98% |
management commentary, guidance changes, and full analysis available with Pro.
| -5.98% |
Tone: Cautiously Optimistic
Overall, management conveyed a sense of cautious optimism despite missing EPS expectations. They are committed to navigating current market challenges.
Management highlighted ongoing challenges in the market but remains focused on long-term growth.
They emphasized the importance of innovation in driving future sales.
Boston Scientific's earnings report indicates a slight miss on EPS expectations, which contributed to a 1.25% decline in stock price. The company is facing market challenges, but management remains focused on long-term growth through innovation. Investors may be cautious as there was no guidance update provided.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
KIMBERLY CLARK CORP
Apr 22, 2019